Discontinued — last reported Q4 '25

Financing

Sale of Subsidiary Stock

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ4 2025

How to read this metric

Positive proceeds indicate successful monetization of assets, while the absence of such activity suggests a focus on retaining control of existing subsidiaries.

Detailed definition

This captures the cash proceeds or financial impact resulting from the sale of equity interests in a subsidiary. It refl...

Peer comparison

Often reported under 'Proceeds from sale of investments' or 'Divestitures' in the investing section.

Metric ID: wmt_sale_of_subsidiary_stock

Historical Data

1 periods
 Q1 '26
Value$0.00

Frequently Asked Questions

What is Medline, Inc. 's sale of subsidiary stock?
Medline, Inc. (MDLN) reported sale of subsidiary stock of $0.00 in Q1 2026.
What does sale of subsidiary stock mean?
Cash generated from selling shares of a subsidiary company.